Recently, the United States Food and Drug Administration (FDA) approved a new drug Erivedge for the treatment of basal cell carcinoma. This is the first drug ever approved for the treatment of basal cell carcinoma.
Basal cell carcinoma is the most common type of cancer in skin cancer. The typical treatment for basal cell carcinoma involves frozen or surgical removal of the cancerous area. Erivadge is suitable for patients with advanced cancer who cannot undergo surgery or chemotherapy, and patients whose cancer cells have spread to other body organs.
The label on the Erivadge bottle warns that if this drug is used for pregnant women it may cause the baby to die; its most common adverse reactions include muscle spasms, hair loss, weight loss, diarrhea, fatigue, altered or loss of taste, loss of appetite, constipation, and vomiting.
It is understood that the FDA originally planned to decide on March 8 whether to approve Erivedge. Now the decision to approve it in advance takes into account that there is no drug for treating basal cell carcinoma.
Basal cell carcinoma is generally not fatal, but if left unchecked, it may lead to disfigurement. There are also a small number of cases showing that basal cell carcinoma may spread to other organs of the body and eventually lead to death.
Basal cell carcinoma is the most common type of cancer in skin cancer. The typical treatment for basal cell carcinoma involves frozen or surgical removal of the cancerous area. Erivadge is suitable for patients with advanced cancer who cannot undergo surgery or chemotherapy, and patients whose cancer cells have spread to other body organs.
The label on the Erivadge bottle warns that if this drug is used for pregnant women it may cause the baby to die; its most common adverse reactions include muscle spasms, hair loss, weight loss, diarrhea, fatigue, altered or loss of taste, loss of appetite, constipation, and vomiting.
It is understood that the FDA originally planned to decide on March 8 whether to approve Erivedge. Now the decision to approve it in advance takes into account that there is no drug for treating basal cell carcinoma.
Basal cell carcinoma is generally not fatal, but if left unchecked, it may lead to disfigurement. There are also a small number of cases showing that basal cell carcinoma may spread to other organs of the body and eventually lead to death.
The valve stem is an important part of the valve.
It is used to drive, connect the actuating mechanism or handle, and directly
drive the spool to move or rotate, so as to realize the function of valve switch
or regulation.Valve stem in the valve opening and closing process is not only
moving parts, stress components, but also seals. At the same time, it is
subjected to the impact and corrosion of the medium, and it also causes friction
with the packing. Therefore, in selecting the stem material, it must be
guaranteed that it has sufficient strength at the prescribed temperature, good
impact toughness, scratch resistance, corrosion resistance. The valve stem is a
vulnerable part, and the mechanical performance and heat treatment performance
of the material should be paid attention to when selecting.The valve stem in the
valve opening and closing process, under tension, compression and torsion force,
and direct contact with the media, as well as the relative motion between the
friction and filler, so in the choice of stem material, must ensure that it
provides adequate temperature strength, good impact toughness, abrasion
resistance and corrosion resistance of.
Marine Valve Parts,Steel Marine Valve Parts,Marine Valves,Marine Ball Valves,Marine Spare Parts
ZhouShan HeCheng Machinery Co., LTD. , https://www.hcmarineparts.com